首页> 外文期刊>Journal of Surgical Oncology >Outcomes in thoracic surgical management of non-small cell lung cancer.
【24h】

Outcomes in thoracic surgical management of non-small cell lung cancer.

机译:非小细胞肺癌胸外科治疗的结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Thoracic surgeons traditionally have measured their outcomes in terms of mortality, complication rates, recurrence patterns, and long-term survival for their cancer patients. These metrics of quality continue to be important today, but increasingly surgeons are under scrutiny for resource utilization, patient experience, and cost effectiveness. Intelligent decisions about resource use require knowledge of utility, disutility, and cost -- information that is still limited and not easily implemented at the time treatment decisions are made. If we accept the proposition that lung cancer care requires a multidisciplinary team making best use of available resources to minimize unwarranted variation, maximize outcomes, and control costs, then three critical needs can be identified: consensus on goals, robust data, and alignment of incentives across disciplines.
机译:传统上,胸外科医师根据其癌症患者的死亡率,并发症发生率,复发模式和长期生存来衡量其预后。这些质量指标在今天仍然很重要,但是越来越多的外科医生正在对资源利用,患者经验和成本效益进行审查。有关资源使用的明智决策需要实用,不实用和成本方面的知识-在制定治疗决策时,这些信息仍然有限且不易实施。如果我们接受这样的主张,即肺癌护理需要一个多学科的团队来充分利用可用资源以最大程度地减少不必要的变异,最大化结果并控制成本,那么就可以确定三个关键需求:关于目标,可靠数据和激励措施的共识。跨学科。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号